BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
7/12/2021 5:45:28 AM | Browse: 703 | Download: 1589
 |
Received |
|
2021-02-03 15:27 |
|
Peer-Review Started |
|
2021-02-03 15:44 |
|
First Decision by Editorial Office Director |
|
2021-03-01 00:52 |
|
Return for Revision |
|
2021-03-01 00:52 |
|
Revised |
|
2021-04-16 18:48 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2021-06-16 13:22 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2021-06-16 13:54 |
|
Articles in Press |
|
2021-06-16 13:54 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2021-06-27 14:27 |
|
Publish the Manuscript Online |
|
2021-07-12 05:45 |
| ISSN |
1948-9358 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Immunology |
| Manuscript Type |
Review |
| Article Title |
Immunometabolic bases of type 2 diabetes in the severity of COVID-19
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Rebeca Viurcos-Sanabria and Galileo Escobedo |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| Fondo Sectorial de Investigación para la Educación-CONACYT-México |
CB-2016-01-286209 |
| Fondo Sectorial de Investigación y Desarrollo en Salud y Seguridad Social SS/IMSS/ISSSTE/CONACYT-México |
SALUD-2017-02-290345 |
|
| Corresponding Author |
Galileo Escobedo, PhD, Full Professor, Laboratorio de Proteómica, Dirección de Investigación, Hospital General de Mexico “Dr. Eduardo Liceaga”, Dr. Balmis 148, Mexico City 06720, Mexico. gescobedog@msn.com |
| Key Words |
COVID-19; SARS-CoV-2; Type 2 Diabetes; Inflammation; Hyperglycemia; Prothrombotic state |
| Core Tip |
Type 2 diabetes (T2D) acts in synergy with severe acute respiratory syndrome coronavirus-2 infection to increase the progression, severity, and mortality of coronavirus disease 2019 (COVID-19). Thus, the immunometabolic bases of the main etiological factors of T2D that contribute to the severity of COVID-19 should be studied. Here, we discuss the molecular mechanisms by which immune cells, hyperglycemia, hyperinsulinemia, loss of pancreatic β-cell mass, insulin resistance, advanced glycation end products, endothelial dysfunction, and prothrombotic state contribute to the severity of COVID-19. The syndemic between COVID-19 and T2D has challenged our ability to identify patients with high mortality risk based on scientific evidence. |
| Publish Date |
2021-07-12 05:45 |
| Citation |
Viurcos-Sanabria R, Escobedo G. Immunometabolic bases of type 2 diabetes in the severity of COVID-19. World J Diabetes 2021; 12(7): 1026-1041 |
| URL |
https://www.wjgnet.com/1948-9358/full/v12/i7/1026.htm |
| DOI |
https://dx.doi.org/10.4239/wjd.v12.i7.1026 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
